ACC15 Presentations Make Nonsurgical Aortic Valve Replacement Look Very Promising
At the ACC meetings yesterday, several “late-breaking clinical trial” presentations provided substantial reasons to be enthusiastic about transcutaneous aortic valve replacement (TAVR) in comparison to standard surgical AV replacement (SAVR).